World's Best Scientists 2026 revealed!
Grard A. P. Nieuwenhuijzen

Grard A. P. Nieuwenhuijzen

D-Index & Metrics

Medicine

D-Index
79
Citations
24874
World Ranking
17485
National Ranking
659

Overview

Grard A. P. Nieuwenhuijzen is affiliated with Catharina Ziekenhuis in the Netherlands. Their research primarily concentrates on medical fields, with a significant focus on surgery and oncology in relation to gastrointestinal diseases.

Their main fields of study include Medicine, with substantial contributions to Surgery, Pulmonary and Respiratory Medicine, and Oncology. Subfields extend to Cancer Research and Gastroenterology, highlighting a multidisciplinary approach within clinical and surgical oncology.

The scientist's key research topics cover:

  • Esophageal Cancer Research and Treatment
  • Gastric Cancer Management and Outcomes
  • Esophageal and GI Pathology
  • Lung Cancer Diagnosis and Treatment
  • Colorectal Cancer Surgical Treatments
  • Colorectal and Anal Carcinomas
  • Cardiac, Anesthesia and Surgical Outcomes

Nieuwenhuijzen's frequent publication venues reflect specialization in surgical oncology and related disciplines. The most common journals include:

  • European Journal of Surgical Oncology
  • Diseases of the Esophagus
  • British Journal of Surgery
  • Annals of Surgical Oncology
  • Annals of Surgery

Collaborations with other researchers are evident, with frequent coauthors being:

  • Camiel Rosman
  • Misha Luyer
  • Ewout A. Kouwenhoven
  • Suzanne S. Gisbertz
  • Sjoerd M. Lagarde

Their recent published papers illustrate ongoing research interests and clinical trial involvement. Selected recent works include:

  • Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial, 2020, The Lancet Oncology
  • Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial, 2021, Journal of Clinical Oncology
  • Radiotherapy or Surgery of the Axilla After a Positive Sentinel Node in Breast Cancer: 10-Year Results of the Randomized Controlled EORTC 10981-22023 AMAROS Trial, 2022, Journal of Clinical Oncology
  • Laparoscopic Versus Open Gastrectomy for Gastric Cancer (LOGICA): A Multicenter Randomized Clinical Trial, 2021, Journal of Clinical Oncology
  • Intrathoracic vs Cervical Anastomosis After Totally or Hybrid Minimally Invasive Esophagectomy for Esophageal Cancer, 2021, JAMA Surgery

Best Publications

  • Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial

    Joel Shapiro;J Jan B van Lanschot;Maarten C C M Hulshof;Pieter van Hagen

  • Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial

    Mila Donker;Geertjan van Tienhoven;Marieke E Straver;Philip Meijnen

  • Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial.

    Renu R Bahadoer;Esmée A Dijkstra;Boudewijn van Etten;Corrie A M Marijnen;Corrie A M Marijnen

  • Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ failure.

    R.M.H. Roumen;T. Hendriks;J. van der Ven-Jongekrijg;G.A. Nieuwenhuijzen

  • Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial

    Ben M Eyck;J Jan B van Lanschot;J Jan B van Lanschot;Maarten C C M Hulshof;Berend J van der Wilk

  • Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy

    M.P. Schijven;A.J.J.M. Vingerhoets;H.J.T. Rutten;G.A.P. Nieuwenhuijzen

  • Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: a population-based study

    W.J. Louwman;M.L.G. Janssen-Heijnen;S. Houterman;A.C. Voogd

  • Oncological outcome of malignant colonic obstruction in the Dutch Stent-In 2 trial

    D. A. M. Sloothaak;M. W. van den Berg;M. G. W. Dijkgraaf;P. Fockens

  • Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study.

    Bo Jan Noordman;Manon C W Spaander;Roelf Valkema;Bas P L Wijnhoven

  • Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancer.

    Raphaëla C. Dresen;Marleen J. Gosens;Hendrik Martijn;Grard A. Nieuwenhuijzen

  • Reduction of Postoperative Ileus by Early Enteral Nutrition in Patients Undergoing Major Rectal Surgery Prospective, Randomized, Controlled Trial

    Petra G. Boelens;Fanny F. B. M. Heesakkers;Misha D. P. Luyer;Kevin W. Y. van Barneveld

  • Laparoscopic cholecystectomy versus percutaneous catheter drainage for acute cholecystitis in high risk patients (CHOCOLATE): multicentre randomised clinical trial

    Charlotte S Loozen;Hjalmar C van Santvoort;Peter van Duijvendijk;Marc Gh Besselink

  • Learning Curve and Associated Morbidity of Minimally Invasive Esophagectomy: A Retrospective Multicenter Study

    Frans van Workum;Marianne H. B. C. Stenstra;Gijs H. K. Berkelmans;Annelijn E. Slaman

  • Neoadjuvant chemoradiotherapy plus surgery versus active surveillance for oesophageal cancer: a stepped-wedge cluster randomised trial

    Bo Jan Noordman;Bas P. L. Wijnhoven;Sjoerd M. Lagarde;Jurjen J. Boonstra

  • Defining Benchmarks for Transthoracic Esophagectomy: A Multicenter Analysis of Total Minimally Invasive Esophagectomy in Low Risk Patients.

    Henner M. Schmidt;Susanne S. Gisbertz;Johnny Moons;Ioannis Rouvelas

  • Circumferential Margin Involvement Is the Crucial Prognostic Factor after Multimodality Treatment in Patients with Locally Advanced Rectal Carcinoma

    Marleen J.E.M. Gosens;René A. Klaassen;Ivonne Tan-Go;Harm J.T. Rutten

  • Safety and effectiveness of SGM-101, a fluorescent antibody targeting carcinoembryonic antigen, for intraoperative detection of colorectal cancer: a dose-escalation pilot study.

    Leonora S F Boogerd;Charlotte E S Hoogstins;Dennis P Schaap;Miranda Kusters

  • Laparoscopic Versus Open Gastrectomy for Gastric Cancer (LOGICA): A Multicenter Randomized Clinical Trial

    Arjen van der Veen;Hylke J F Brenkman;Maarten F J Seesing;Leonie Haverkamp

  • Increased incidence and survival for oesophageal cancer but not for gastric cardia cancer in the Netherlands

    Johan L. Dikken;Johan L. Dikken;Valery E. Lemmens;Michel W.J.M. Wouters;Bas P. Wijnhoven

  • Clinical management of women with metastatic breast cancer: a descriptive study according to age group.

    Klaartje Manders;Lonneke V van de Poll-Franse;Geert-Jan Creemers;Gerard Vreugdenhil

Frequent Co-Authors

Richard van Hillegersberg
Richard van Hillegersberg Utrecht University
Peter D. Siersema
Peter D. Siersema Radboud University
Ewout W. Steyerberg
Ewout W. Steyerberg Leiden University Medical Center
Cornelis J.H. van de Velde
Cornelis J.H. van de Velde Leiden University Medical Center
Ignace H. J. T. de Hingh
Ignace H. J. T. de Hingh Maastricht University
Hugo W. Tilanus
Hugo W. Tilanus Erasmus University Rotterdam
Cornelis J. A. Punt
Cornelis J. A. Punt University of Amsterdam
Olivier R. Busch
Olivier R. Busch University of Amsterdam
Jan Willem Coebergh
Jan Willem Coebergh Erasmus University Rotterdam
Henk M.W. Verheul
Henk M.W. Verheul Radboud University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring related online degrees can open additional pathways in healthcare. Many students interested in Medicine pursue nursing qualifications online, drawn by flexibility and affordability. When considering how much is online nursing school, it’s essential to compare tuition, accreditation, and financial aid to find the best fit.

Advancing in your career may involve earning an online nursing doctorate. These programs are designed for working professionals seeking leadership or academic roles. Many institutions also offer cheap rn to bsn online programs that allow registered nurses to complete their bachelor's degree affordably and at their own pace.

Aspiring nurses without a nursing background can fast-track healthcare careers through non nursing bachelor's to msn online programs. These pathways help diverse students transition into the nursing field quickly, offering both flexibility and strong career prospects.

Best Scientists Citing Grard A. P. Nieuwenhuijzen

Trending Scientists

Recently Published Articles